The use of atezolizumab combination therapy in the EGFR+ metastatic non-squamous NSCLC setting: practical guidance based on early clinical experience. (January 2020) - Geldart, T.; Belitei, P.; Benepal, T.; Mehta, A.; Baijal, S.; Denton, A.; Escriu, C.; Chitnis, M.; Bennett, M.; Popat, S.